Evidence map›Paper›PMID 32279069›Full record

SynthesisNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Shared genetic background between children and adults with attention deficit/hyperactivity disorder.

Paula Rovira, Ditte Demontis, Cristina Sánchez-Mora, Tetyana Zayats, Marieke Klein, Nina Roth Mota, Heike Weber, Iris Garcia-Martínez, Mireia Pagerols, Laura Vilar-Ribó and 46 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 4 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 4 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  11. Cut from the same cloth: neurobiological continuity between childhood and adult ADHD.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors at 15 institutions in 10 countries.

Paula Rovira *Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Ditte Demontis *Department of Biomedicine (Human Genetics), and Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9124-2766
Cristina Sánchez-MoraPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.ORCID http://orcid.org/0000-0003-4211-1107
Tetyana ZayatsDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Marieke KleinDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-8784-5679
Nina Roth MotaDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Heike WeberDepartment of Psychiatry, Psychosomatics, and Psychotherapy, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-9421-1292
Iris Garcia-MartínezPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Mireia PagerolsPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Laura Vilar-RibóPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Lorena ArribasPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Vanesa RicharteDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Montserrat CorralesDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Christian FadeuilheDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Rosa BoschDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Gemma Español MartinDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain.
Peter AlmosDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
Alysa E DoyleCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Eugenio Horacio GrevetADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Oliver GrimmDepartment of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
Anne HalmøyDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Martine HoogmanDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Mara HutzDepartment of Genetics, Institute of Biosciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Christian P JacobDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
Sarah Kittel-SchneiderDepartment of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
Per M KnappskogCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Astri J LundervoldDepartment of Biological and Medical Psychology, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-6819-6164
Olga RiveroDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-2664-4053
Diego Luiz RovarisADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-8910-4927
Angelica Salatino-OliveiraDepartment of Genetics, Institute of Biosciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Bruna Santos da SilvaADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Evgeniy SvirinDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-3501-574X
Emma SprootenDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Tatyana StrekalovaDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
ADHD Working Group of the Psychiatric Genomics Consortium
23andMe Research team
Alejandro Arias-VasquezDepartment of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Edmund J S Sonuga-BarkeInstitute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Philip AshersonSocial Genetic and Developmental Psychiatry, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
Claiton Henrique Dotto BauADHD Outpatient Program, Adult Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Jan K BuitelaarDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-8288-7757
Bru CormandDepartment of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
Stephen V FaraoneDepartments of Psychiatry, of Neuroscience, and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
Jan HaavikDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0001-7865-2808
Stefan E JohanssonCenter for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0002-2298-7008
Jonna KuntsiSocial Genetic and Developmental Psychiatry, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-0113-8162
Henrik LarssonSchool of medical Sciences, Örebro University, Örebro, Sweden.
Klaus-Peter LeschDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-8348-153X
Andreas ReifDepartment of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-0992-634X
Luis Augusto RohdeDivision of Child Psychiatry, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Miquel CasasPsychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Anders D Børglum *Department of Biomedicine (Human Genetics), and Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-8627-7219
Barbara Franke *Department of Human Genetics, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-4375-6572
Josep Antoni Ramos-Quiroga *Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.ORCID http://orcid.org/0000-0003-1622-0350
María Soler Artigas *Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. maria.soler@vhir.org.
Marta Ribasés *Psychiatric Genetics Unit, Group of Psychiatry, Mental Health, and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. marta.ribases@vhir.org.ORCID http://orcid.org/0000-0003-1039-1116
Universitat Autònoma de Barcelona · ESRadboud University Nijmegen · NLUniversidade Federal do Rio Grande do Sul · BRGoethe University Frankfurt · DEHaukeland University Hospital · NOKing's College London · GBSechenov University · RUUniversity of Würzburg · DEAarhus University · DKBroad Institute · USCentre for Biomedical Network Research on Rare Diseases · ESHarvard University · USÖrebro University · SESUNY Upstate Medical University · USUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.

Indexed as

Attention Deficit Disorder with HyperactivityAdultChildGenetic BackgroundGenome-Wide Association StudyHumansImpulsive BehaviorPhenotype

Identifiers

PMID32279069
PMCPMC7419307
OpenAlexW3015807187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.